INOX Air Products, an industrial and medical gases maker with operations across India, has filed draft papers for an initial public offering. The key detail for investors: the deal is structured as a pure secondary sale, meaning the company itself will not receive any new capital. Instead, existing shareholders — including top holder Prodair Corp, a unit of Air Products and Chemicals — are trimming their stakes.
That structure matters. In a typical IPO, a company sells new shares to fund expansion, pay down debt, or invest in growth. In a secondary sale, the proceeds go to selling shareholders, not the business. For INOX Air Products, the filing is therefore less about raising money and more about giving existing investors a path to cash out and establishing a public market for the stock.
What INOX Air Products does — and why it matters
Industrial and medical gases are a quiet but essential part of the economy. The company supplies gases such as oxygen, nitrogen, and argon to manufacturers, hospitals, and infrastructure projects. Demand tends to track industrial activity, healthcare spending, and construction — making the business a proxy for broader economic growth.
According to its draft papers cited by Reuters, INOX Air Products operates 57 sites across India and reported a profit of 9.14 billion rupees on revenue of 30.34 billion rupees for the year ended March 31. Those figures give investors a rare look at the financials of a privately held player in a sector that is often overlooked.
The company’s ownership structure is also notable. Prodair Corp, an arm of U.S.-listed Air Products and Chemicals, is the top shareholder. Its decision to sell down part of its stake in the IPO could signal a shift in strategy or simply a desire to monetise a long-held investment. Other shareholders are also reducing their holdings, according to the filing.
India’s IPO market is warming up
The filing comes as India’s IPO market is showing signs of life again after a quieter stretch. Several companies have lined up listings, and investor appetite for new issues appears to be returning. That backdrop may have encouraged INOX Air Products and its shareholders to move ahead with the offering.
For everyday investors, the deal offers a way to gain exposure to a business tied to India’s industrial and healthcare growth. But it also comes with caveats. Because the IPO is a secondary sale, the company won’t get a cash injection to fund expansion or reduce debt. That means the growth story depends entirely on the company’s existing operations and its ability to generate cash internally.
Investors should also watch how the selling shareholders behave after the listing. If Prodair Corp and others continue to sell down their stakes, it could put pressure on the share price. Conversely, if they retain a significant holding, it may signal confidence in the company’s prospects.
What it means for investors
For those considering the IPO, the first question is valuation. The draft papers will eventually include a price band, which will determine whether the shares look cheap or expensive relative to peers. Industrial gas companies often trade at premium valuations because of their steady, contract-based revenues and high barriers to entry. But without fresh capital coming in, the company’s growth will rely on its own cash flow.
It’s also worth noting that secondary sales are common in India and elsewhere. They allow private equity firms, founders, and strategic investors to exit part of their holdings while bringing a company to the public markets. For retail investors, the key is to understand who is selling and why. In this case, a major global player like Air Products is reducing its exposure — a detail that may prompt questions about its long-term commitment to the Indian venture.
Beyond the company itself, the IPO adds to a growing pipeline of Indian listings. That could be a positive sign for market sentiment, but it also means investors will have more choices — and more reason to be selective. As always, reading the risk factors in the draft papers is essential, especially for a business tied to industrial cycles and hospital demand.
For now, the filing is just the first step. The company will need regulatory approval, and the actual listing could take months. Investors should watch for the price band, the final size of the offer, and any changes in the selling shareholders’ plans. Those details will shape whether this IPO is a compelling opportunity or one to watch from the sidelines.
